# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Mizuho analyst Anthony Petrone maintains Establishment Labs Hldgs (NASDAQ:ESTA) with a Buy and raises the price target from ...
The inspection by the FDA has been rescheduled from the previously confirmed dates to take place within the next thirty days.
Citigroup analyst Joanne Wuensch downgrades Establishment Labs Hldgs (NASDAQ:ESTA) from Buy to Neutral and maintains the pri...
Establishment Labs Hldgs (NASDAQ:ESTA) reported quarterly losses of $(0.58) per share which beat the analyst consensus estimate...
Establishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company dedicated to improving women's health a...
Citigroup analyst Joanne Wuensch maintains Establishment Labs Hldgs (NASDAQ:ESTA) with a Buy and raises the price target fro...